Skip to Content
Merck
  • Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 2. Parameters determining microsphere formation.

Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 2. Parameters determining microsphere formation.

Journal of pharmaceutical sciences (1998-04-02)
C Thomasin, H P Merkle, B Gander
ABSTRACT

Phase separation (frequently called coacervation) of poly(lactide) (PLA) and poly(lactide-co-glycolide) (PLGA) is a classical method for drug microencapsulation. Here, attempts have been made to describe this process in the light of thermodynamics. Different PLA/PLGAs were dissolved in either dichloromethane or ethyl acetate, phase separated by addition of the coacervating agent silicone oil (PDMS), and hardened in either octamethylcyclotetrasiloxane or hexane. Various stages of phase separation were defined microscopically, and the coacervate and continuous phases characterized with respect to volume, composition, polymer molecular weight, and rheological behavior. The optimal amount of PDMS was inversely proportional to the polymer molecular weight and hydrophilicity, and a coacervate viscosity of above 5-10 Pa s was required for stable coacervate droplets. The composition and, consequently, viscosity of the coacervate and continuous phases depended on the polymer-solvent-PDMS interactions, as analyzed by the parameters chi (Flory), delta (Hildebrand), and delta(int)E (Hô). In general, the lattice model of FIory and Scott describing polymer-polymer incompatibility best explained the results. The interaction parameters and viscosity of the phases were also helpful to explain microsphere characteristics such as residual solvent and particle size. The data suggest that microsphere formation by polyester coacervation is primarily driven by molecular interactions between polymer, solvents, and coacervating agent.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
NanoFabTx PEGylated nanoparticle formulation screening kit
Sigma-Aldrich
NanoFabTx materials screening kit, for synthesis of polymeric nanoparticles
Sigma-Aldrich
NanoFabTx NanoFlash PEG-PLA drug formulation screening kit, for CIJ synthesis of nanoparticles
Sigma-Aldrich
NanoFabTx NanoFlash PEG-PCL drug formulation screening kit, for CIJ synthesis of nanoparticles
Sigma-Aldrich
NanoFabTx PEG-PLA drug formulation screening kit, for synthesis of PEGylated nanoparticles
Sigma-Aldrich
NanoFabTx PLA-nano, for synthesis of 100 and 200 nm particles